SAB Biotherapeutics, Inc. Quarterly Employee-related Liabilities, Current in USD from Q4 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
SAB Biotherapeutics, Inc. quarterly Employee-related Liabilities, Current history and growth rate from Q4 2023 to Q2 2024.
  • SAB Biotherapeutics, Inc. Employee-related Liabilities, Current for the quarter ending June 30, 2024 was $2.84M.
Employee-related Liabilities, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.84M Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.92M Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $3.4M Dec 31, 2023 10-Q 2024-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.